Aquagene

Alachua, United States Founded: 1996 • Age: 30 yrs
Produces high-quality recombinant proteins for research and industrial applications.
Annual revenue - Latest available
Total funding $980,000 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Aquagene

Aquagene is a company based in Alachua (United States) founded in 1996. It operates as a B2B. Aquagene has raised $980 thousand across 2 funding rounds from investors including Advantage Capital. Aquagene operates in a competitive market with competitors including Encodia, Tierra Biosciences, Amide Technologies, Kesmalea and mk2 Biotechnologies, among others.

  • Headquarter Alachua, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $980 K (USD)

    in 2 rounds

  • Latest Funding Round
    $400 K (USD), Unspecified

    Nov 05, 2001

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aquagene

Aquagene has successfully raised a total of $980K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $400 thousand completed in November 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Aquagene

Aquagene has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advantage Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investment firm
Locked Locked Locked
Premium access

Investor details for Aquagene

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aquagene

Investments
Premium access

Investment portfolio details for Aquagene

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aquagene

Premium access

Detailed financials for Aquagene

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aquagene Comparisons

Aquagene Primary company
Description
Produces high-quality recombinant proteins for research and ...
Location
Alachua, United States
Founded Year
1996
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Aquagene

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aquagene

Aquagene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Encodia, Tierra Biosciences, Amide Technologies, Kesmalea and mk2 Biotechnologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Technology platforms for integrative proteomic analysis are developed.
Locked Locked Locked
AI-based tools for protein development and custom synthesis are offered.
Locked Locked Locked
Automated peptide synthesis platform is developed with precision reagents.
Locked Locked Locked
Protein homeostasis modulators are developed for therapeutic applications.
Locked Locked Locked
Peptides and proteins are developed for life science applications.
Premium access

Detailed competitors of Aquagene

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aquagene

Premium access

Complete news archive for Aquagene

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aquagene

Aquagene was founded in 1996 and raised its 1st funding round 4 years after it was founded.

Aquagene is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.

Aquagene is a funded company, having raised a total of $980K across 2 funding rounds to date.

Aquagene produces high-quality recombinant proteins for research and industrial applications, focusing on providing healthcare solutions, advancing biotech innovations, recombinant proteins, and production and manufacturing. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Aquagene's top competitors include Encodia, Tierra Biosciences and Amide Technologies.

Aquagene has 1 investor. Key investors include Advantage Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available